
|Articles|January 4, 2022
Pharmacy Clinical Pearl of the Day: Gastrointestinal Stromal Tumors
Author(s)Saro Arakelians, PharmD
Small GISTs may cause no symptoms and may grow so slowly that they have no serious effects.
Advertisement
Clinical Pearl of the Day: Gastrointestinal Stromal Tumors
Gastrointestinal stromal tumors (GISTs) are soft tissue sarcomas located in any part of the digestive system.
Insight:
- Their most common sites are the stomach and small intestine.
- GISTs start in specialized nerve cells located in the walls of the digestive system. These cells are part of the autonomic nervous system.
- A specific change in the DNA of any of these cells, which control digestive processes such as movement of food through the intestines, gives rise to a GIST.
- Small GISTs may cause no symptoms and may grow so slowly that they have no serious effects.
- People with larger GISTs usually seek medical attention when they vomit blood or pass blood in their stool due to rapid bleeding from the tumor.
- Diagnosis starts with upper endoscopy, ultrasound, laboratory tests and biopsy, CT-scan.
- Treatment starts with surgery, targeted drug therapy, with medications such as imatinib (Gleevac) and others.
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
2
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
3
IRAKLIA Trial Shows Body Weight Doesn’t Alter Outcomes With On-Body Injector Isatuximab
4
Advancing Precision Oncology: Perspectives for Pharmacists on MRD Testing and Diagnostic Innovation
5

















































































































































































































